Swedbank AB raised its stake in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 6.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 102,176 shares of the company's stock after buying an additional 6,484 shares during the period. Swedbank AB owned 0.19% of Molina Healthcare worth $30,438,000 at the end of the most recent quarter.
Other institutional investors also recently modified their holdings of the company. Rothschild Investment LLC grew its stake in shares of Molina Healthcare by 126.3% in the first quarter. Rothschild Investment LLC now owns 86 shares of the company's stock worth $28,000 after purchasing an additional 48 shares during the last quarter. Zions Bancorporation National Association UT bought a new stake in shares of Molina Healthcare in the first quarter worth $29,000. Deseret Mutual Benefit Administrators grew its stake in shares of Molina Healthcare by 60.7% in the first quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock worth $30,000 after purchasing an additional 34 shares during the last quarter. Elequin Capital LP grew its stake in shares of Molina Healthcare by 170.6% in the first quarter. Elequin Capital LP now owns 92 shares of the company's stock worth $30,000 after purchasing an additional 58 shares during the last quarter. Finally, Silver Oak Securities Incorporated bought a new stake in shares of Molina Healthcare in the first quarter worth $34,000. Institutional investors own 98.50% of the company's stock.
Insider Activity
In related news, COO James Woys acquired 10,000 shares of the company's stock in a transaction dated Monday, August 4th. The shares were purchased at an average price of $155.94 per share, for a total transaction of $1,559,400.00. Following the completion of the acquisition, the chief operating officer owned 74,331 shares of the company's stock, valued at approximately $11,591,176.14. This trade represents a 15.54% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Ronna Romney sold 700 shares of the company's stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total transaction of $107,618.00. Following the transaction, the director owned 17,131 shares in the company, valued at $2,633,719.94. This represents a 3.93% decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
MOH has been the topic of several analyst reports. Wall Street Zen cut shares of Molina Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, June 29th. UBS Group reduced their price objective on shares of Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating on the stock in a research note on Friday, July 25th. Sanford C. Bernstein reduced their price objective on shares of Molina Healthcare from $284.00 to $220.00 and set an "outperform" rating on the stock in a research note on Friday, September 5th. Robert W. Baird reduced their price objective on shares of Molina Healthcare from $373.00 to $179.00 and set a "neutral" rating on the stock in a research note on Friday, July 25th. Finally, Truist Financial restated a "hold" rating and issued a $180.00 target price (down previously from $335.00) on shares of Molina Healthcare in a report on Friday, July 25th. Three investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $225.18.
Check Out Our Latest Research Report on Molina Healthcare
Molina Healthcare Price Performance
MOH stock opened at $175.09 on Friday. The firm has a market cap of $9.49 billion, a price-to-earnings ratio of 8.63 and a beta of 0.54. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.77. Molina Healthcare, Inc has a 12-month low of $151.95 and a 12-month high of $359.97. The company's fifty day simple moving average is $174.11 and its 200 day simple moving average is $262.02.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.50 by ($0.02). The firm had revenue of $11.43 billion during the quarter, compared to analyst estimates of $10.94 billion. Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. Molina Healthcare's quarterly revenue was up 15.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $5.86 EPS. On average, analysts expect that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.